{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:00:32Z","timestamp":1791219632570,"version":"4.1.0"},"reference-count":183,"publisher":"SAGE Publications","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2015,9,24]]},"DOI":"10.3233\/jad-150202","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T16:22:51Z","timestamp":1445358171000},"page":"S171-S191","source":"Crossref","is-referenced-by-count":48,"title":["Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline"],"prefix":"10.1177","volume":"48","author":[{"given":"Simone","family":"Lista","sequence":"first","affiliation":[{"name":"AXA Research Fund & UPMC Chair, Paris, France"},{"name":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie (UPMC), Paris 06, Institut de la M\u00e9moire et de la Maladie d\u2019Alzheimer (IM2A) & Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), UMR S 1127, D\u00e9partement de Neurologie, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Molinuevo","sequence":"additional","affiliation":[{"name":"Alzheimers Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Cavedo","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie (UPMC), Paris 06, Institut de la M\u00e9moire et de la Maladie d\u2019Alzheimer (IM2A) & Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), UMR S 1127, D\u00e9partement de Neurologie, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"},{"name":"CATI Multicenter Neuroimaging Platform, France"},{"name":"Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Istituto Centro \u201cSan Giovanni diDio-Fatebenefratelli\u201d, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rami","sequence":"additional","affiliation":[{"name":"Alzheimers Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Barcelona, Spain"},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Amouyel","sequence":"additional","affiliation":[{"name":"Inserm, U1157, Lille, France"},{"name":"Universit\u00e9 de Lille, Lille, France"},{"name":"Institut Pasteur de Lille, Lille, France"},{"name":"Centre Hospitalier R\u00e9gional Universitaire de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J.","family":"Teipel","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany & German Center forNeurodegenerative Diseases (DZNE) Rostock\/Greifswald, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Garaci","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, University Hospital of \u201cTor Vergata\u201d, Rome, Italy"},{"name":"Department of Biomedicine and Prevention University of Rome \u201cTor Vergata\u201d, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Toschi","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention University of Rome \u201cTor Vergata\u201d, Rome, Italy"},{"name":"Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Odile","family":"Habert","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Univ Paris 06, Inserm U 1146, CNRS UMR 7371, Laboratoire d\u2019Imagerie Biom\u00e9dicale, Paris, France"},{"name":"AP-HP, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, Nuclear Medicine Department, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"The Torsten S\u00f6derberg Professorship in Medicine at the Royal Swedish Academy of Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sid E.","family":"O\u2019Bryant","sequence":"additional","affiliation":[{"name":"Institute for Aging and Alzheimer\u2019s Disease Research & Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Johnson","sequence":"additional","affiliation":[{"name":"Institute for Aging and Alzheimer\u2019s Disease Research & Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Galluzzi","sequence":"additional","affiliation":[{"name":"Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS Istituto Centro \u201cSan Giovanni diDio-Fatebenefratelli\u201d, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun L.W.","family":"Bokde","sequence":"additional","affiliation":[{"name":"Cognitive Systems Group, Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland"},{"name":"Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Broich","sequence":"additional","affiliation":[{"name":"President, Federal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Herholz","sequence":"additional","affiliation":[{"name":"Institute of Brain, Behaviours and Mental Health, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hovagim","family":"Bakardjian","sequence":"additional","affiliation":[{"name":"IM2A - Institute of Memory and Alzheimer\u2019s Disease, IHU-A-ICM - Paris Institute of Translational Neurosciences, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dubois","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie (UPMC), Paris 06, Institut de la M\u00e9moire et de la Maladie d\u2019Alzheimer (IM2A) & Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), UMR S 1127, D\u00e9partement de Neurologie, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Cologne, Cologne, Germany"},{"name":"German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Medical & Scientific Relations, Alzheimer\u2019s Association, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Aisen","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, University of California, San Diego, San Diego, CA, USA\u2225"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[{"name":"AXA Research Fund & UPMC Chair, Paris, France"},{"name":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie (UPMC), Paris 06, Institut de la M\u00e9moire et de la Maladie d\u2019Alzheimer (IM2A) & Institut du Cerveau et de la Moelle \u00e9pini\u00e8re (ICM), UMR S 1127, D\u00e9partement de Neurologie, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150202_ref1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrneurol.2012.202","article-title":"Alzheimer disease: From inherited to sporadic AD-crossing the biomarker bridge","volume":"8","author":"Hampel","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-150202_ref3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jalz.2012.05.2116","article-title":"Development of biomarkers to chart all Alzheimer\u2019s disease stages: The royal road to cutting the therapeutic Gordian Knot","volume":"8","author":"Hampel","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcp.2013.11.009","article-title":"Perspective on future role of biological markers in clinical therapy trials of Alzheimer\u2019s disease: A long-range point of view beyond 2020","volume":"88","author":"Hampel","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-150202_ref5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2013.04.506","article-title":"CSF A\u03b21-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer\u2019s disease","volume":"10","author":"Lista","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimer\u2019s disease:Academic industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-150202_ref7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of dementia by subjective memory impairment: Effects of severity and temporal association with cognitive impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-150202_ref8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/WNL.0b013e3182a8418b","article-title":"Preclinical AD predicts decline in memory and executive functions in subjective complaints","volume":"81","author":"van Harten","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jalz.2009.10.002","article-title":"Outcome over seven years of healthy adults with and without subjective cognitive impairment","volume":"6","author":"Reisberg","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/acps.12336","article-title":"Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis","volume":"130","author":"Mitchell","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"10.3233\/JAD-150202_ref11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1474-4422(09)70139-5","article-title":"Prevalence and prognostic value of CSF markers of Alzheimer\u2019s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study","volume":"8","author":"Visser","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150202_ref12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1212\/01.wnl.0000234032.77541.a2","article-title":"Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI","volume":"67","author":"Saykin","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref13","first-page":"223","article-title":"Subjective cognition and amyloid deposition imaging: A Pittsburgh Compound B positron emission tomography study in normal elderly individuals","volume":"69","author":"Perrotin","year":"2012","journal-title":"ArchNeurol"},{"key":"10.3233\/JAD-150202_ref14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2010-101422","article-title":"Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients","volume":"23","author":"Rami","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref15","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.neuropsychologia.2012.08.011","article-title":"Subjective cognitive complaints and amyloid burden in cognitively normal older individuals","volume":"50","author":"Amariglio","year":"2012","journal-title":"Neuropsychologia"},{"key":"10.3233\/JAD-150202_ref16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.0000000000000856","article-title":"Self-reported memory complaints: Implications from a longitudinal cohort with autopsies","volume":"83","author":"Kryscio","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref17","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer\u2019s disease: A new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150202_ref18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Assocation workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10072-010-0224-6","article-title":"Are subjective cognitive complaints a risk factor for dementia?","volume":"31","author":"Gallassi","year":"2010","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-150202_ref20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.0b013e31826e2696","article-title":"Indicators of amyloid burden in a population-based study of cognitively normal elderly","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbadis.2011.08.002","article-title":"Selective changes in white matter integrity in MCI and older adults with cognitive complaints","volume":"1822","author":"Wang","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-150202_ref22","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0b013e31826c1a8d","article-title":"Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment","volume":"79","author":"Scheef","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","article-title":"Cognitively preserved subjects with transitional cerebrospinal fluid \u00df-amyloid 1-42 values have thicker cortex in Alzheimer\u2019s disease vulnerable areas","volume":"70","author":"Fortea","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-150202_ref24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nicl.2013.02.006","article-title":"Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer\u2019s disease","volume":"2","author":"Ch\u00e9telat","year":"2013","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-150202_ref25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and beta-amyloid deposition in Alzheimer disease","volume":"67","author":"Chetelat","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150202_ref26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging and Alzheimer\u2019s Association Workgroup","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref27","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.jalz.2007.11.017","article-title":"The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer\u2019s disease","volume":"4","author":"Reisberg","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J Neuropathol ExpNeurol"},{"key":"10.3233\/JAD-150202_ref29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/WNL.46.3.707","article-title":"Cerebral amyloid deposition and diffuse plaques in \u201cnormal\u201d aging: Evidence for presymptomatic and very mild Alzheimer\u2019s disease","volume":"46","author":"Morris","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neurobiolaging.2004.05.003","article-title":"Apolipoprotein E, cardiovascular disease and cognitive function in aging women","volume":"26","author":"Kang","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref31","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-150202_ref32","first-page":"671","article-title":"Memory complaints in patients with normal cognition are associated with smaller hippocampal volumes","volume":"251","author":"van der Flier","year":"2004","journal-title":"J Neurol"},{"key":"10.3233\/JAD-150202_ref33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/ng.2237","article-title":"Common variants at 12q14 and 12q24 are associated with hippocampal volume","volume":"44","author":"Bis","year":"2012","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-150202_ref34","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(13)60777-1","article-title":"Physical and cognitive functioning of people older than 90 years: A comparison of two Danish cohorts born 10 years apart","volume":"382","author":"Christensen","year":"2013","journal-title":"Lancet"},{"key":"10.3233\/JAD-150202_ref35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer\u2019s disease: An analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150202_ref36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-150202_ref37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp.2006.100529","article-title":"Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women","volume":"78","author":"Gustafson","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-150202_ref38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150202_ref39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000105017","article-title":"Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly","volume":"24","author":"Stomrud","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150202_ref40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneurol.2009.316","article-title":"Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults","volume":"67","author":"Stomrud","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150202_ref41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ana.22315","article-title":"Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Abeta1-42","volume":"68","author":"Schott","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150202_ref42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","article-title":"CSF tau\/Abeta42 ratio for increased risk of mild cognitive impairment: A follow-up study","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000068478","article-title":"Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: A population-based study in 85-year-olds","volume":"15","author":"Skoog","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150202_ref44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jalz.2012.08.004","article-title":"Cerebrospinal fluid Abeta42 is the best predictor of clinical progression in patients with subjective complaints","volume":"9","author":"van Harten","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JAD-2011-110038","article-title":"Amyloid-beta(4)(2) is associated with cognitive impairment in healthy elderly and subjective cognitive impairment","volume":"26","author":"Rolstad","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2010-101422","article-title":"Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients","volume":"23","author":"Rami","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-150202_ref48","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/WNL.0b013e3182704056","article-title":"Injury markers predict time to dementia in subjects with MCI and amyloid pathology","volume":"79","author":"van Rossum","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref49","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","article-title":"Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later","volume":"80","author":"Roe","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archneurol.2010.215","article-title":"A serum protein-based algorithm for the detection of Alzheimer disease","volume":"67","author":"O\u2019Bryant","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150202_ref51","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-141041","article-title":"Validation of a serum screen for alzheimer\u2019s disease across assay platforms, species, and tissues","volume":"42","author":"O\u2019Bryant","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.06.007","article-title":"Blood and plasma-based proteomic biomarker research in Alzheimer\u2019s disease","volume":"101-102","author":"Lista","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-150202_ref53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jalz.2013.10.007","article-title":"Developing novel blood-based biomarkers for Alzheimer\u2019s disease","volume":"10","author":"Snyder","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jalz.2014.05.1749","article-title":"Plasma proteins predict conversion to dementia from prodromal disease","volume":"10","author":"Hye","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref55","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study","volume":"11","author":"Fiandaca","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","article-title":"Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer\u2019s disease research","volume":"11","author":"O\u2019Bryant","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer\u2019s disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref58","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1755-5949.2009.00104.x","article-title":"Biological marker candidates of alzheimer\u2019s disease in blood, plasma, and serum","volume":"15","author":"Schneider","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"10.3233\/JAD-150202_ref59","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/STROKEAHA.108.532853","article-title":"Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints","volume":"40","author":"Kearney-Schwartz","year":"2009","journal-title":"Stroke"},{"key":"10.3233\/JAD-150202_ref60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.archger.2012.07.009","article-title":"Subjective well-being in Swedish active seniors or seniors with cognitive complaints and its relation tocommonly available biomarkers","volume":"56","author":"Olsson","year":"2013","journal-title":"Arch Gerontol Geriatr"},{"key":"10.3233\/JAD-150202_ref61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/mp.2012.147","article-title":"Associations between gonadotropins, testosterone and \u03b2 amyloid in men at risk of Alzheimer\u2019s disease","volume":"19","author":"Verdile","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-150202_ref62","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000321120","article-title":"Association study of gene polymorphisms involved in vascular alterations in elderly hypertensives with subjective memory complaints","volume":"30","author":"Watfa","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150202_ref63","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0306-4522(99)00476-5","article-title":"The histological validation of post mortem magnetic resonance imaging- determined hippocampal volume in Alzheimer\u2019s disease","volume":"95","author":"Bobinski","year":"2000","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-150202_ref64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2004.02.001","article-title":"Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer\u2019s disease","volume":"361","author":"Kril","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150202_ref65","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ana.20503","article-title":"Correlates of hippocampal neuron number in Alzheimer\u2019s disease and ischemic vascular dementia","volume":"57","author":"Zarow","year":"2005","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150202_ref66","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/NEN.0b013e31818fc72f","article-title":"Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease","volume":"67","author":"Freeman","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-150202_ref67","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/WNL.58.5.750","article-title":"Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia","volume":"58","author":"Jack","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref68","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archneur.63.10.1434","article-title":"Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration","volume":"63","author":"Barnes","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150202_ref69","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/brain\/awm319","article-title":"Automatic classification of MR scans in Alzheimer\u2019s disease","volume":"131","author":"Kloppel","year":"2008","journal-title":"Brain"},{"key":"10.3233\/JAD-150202_ref70","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuroimage.2010.12.073","article-title":"Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND","volume":"55","author":"Vemuri","year":"2011","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref71","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0197-4580(01)00271-8","article-title":"MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer\u2019s disease","volume":"22","author":"Dickerson","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref72","first-page":"871","article-title":"Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"64","author":"Devanand","year":"2008","journal-title":"BiolPsychiatry"},{"key":"10.3233\/JAD-150202_ref73","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1002\/hbm.22156","article-title":"Prediction of Alzheimer\u2019s disease and mild cognitive impairment using cortical morphological patterns","volume":"34","author":"Wee","year":"2013","journal-title":"Hum Brain Mapp"},{"key":"10.3233\/JAD-150202_ref74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.neuroimage.2012.09.058","article-title":"Prediction of Alzheimer\u2019s disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning","volume":"65","author":"Eskildsen","year":"2013","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref75","doi-asserted-by":"crossref","first-page":"e55246","DOI":"10.1371\/journal.pone.0055246","article-title":"Predicting AD conversion: Comparison between prodromal AD guidelines and computer assisted PredictAD tool","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-150202_ref76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pscychresns.2012.11.005","article-title":"Different multivariate techniques for automated classification of MRI data in Alzheimer\u2019s disease and mild cognitive impairment","volume":"212","author":"Aguilar","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-150202_ref77","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.neurobiolaging.2013.02.002","article-title":"Measurements of medial temporal lobe atrophy for prediction of Alzheimer\u2019s disease in subjects with mild cognitive impairment","volume":"34","author":"Clerx","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref78","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jagp.2014.07.009","article-title":"Hippocampal atrophy is associated with subjective memory decline: The PATH Through Life study","volume":"23","author":"Cherbuin","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-150202_ref79","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JAD-142322","article-title":"Cortical thinning in individuals with subjective memory impairment","volume":"45","author":"Meiberth","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref80","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.neurobiolaging.2005.10.010","article-title":"Volume reduction of the entorhinal cortex in subjective memory impairment","volume":"27","author":"Jessen","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref81","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1017\/S0033291711000067","article-title":"Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume","volume":"41","author":"Striepens","year":"2011","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-150202_ref82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000264630","article-title":"Volume loss of the medial temporal lobe structures in subjective memory impairment","volume":"29","author":"Striepens","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150202_ref83","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.neurobiolaging.2005.09.035","article-title":"Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints","volume":"27","author":"Wang","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref84","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1192\/bjp.bp.110.078683","article-title":"Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study","volume":"198","author":"Stewart","year":"2011","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-150202_ref85","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.parkreldis.2014.06.011","article-title":"Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson\u2019s disease","volume":"20","author":"Hong","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-150202_ref86","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/brain.2013.0144","article-title":"Increased functional connectivity and brain atrophy in elderly with subjective memory complaints","volume":"3","author":"Hafkemeijer","year":"2013","journal-title":"Brain Connect"},{"key":"10.3233\/JAD-150202_ref87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2013.05.1764","article-title":"Gray matter atrophy pattern in elderly with subjective memory impairment","volume":"10","author":"Peter","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref88","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.neuroimage.2003.07.005","article-title":"Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia","volume":"20","author":"Song","year":"2003","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref89","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.neurobiolaging.2005.03.026","article-title":"White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study","volume":"27","author":"Medina","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref90","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.neurobiolaging.2009.10.006","article-title":"Diffusion tensor imaging and tract-based spatial statistics in Alzheimer\u2019s disease and mild cognitive impairment","volume":"32","author":"Liu","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/WCO.0b013e3282f4594b","article-title":"Diffusion tensor imaging in mild cognitive impairment and Alzheimer\u2019s disease: A review","volume":"21","author":"Chua","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JAD-150202_ref92","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.mri.2007.03.017","article-title":"Diffusion tensor MRI to investigate dementias: A brief review","volume":"25","author":"Bozzali","year":"2007","journal-title":"Magn Reson Imaging"},{"key":"10.3233\/JAD-150202_ref93","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3174\/ajnr.A0700","article-title":"Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: Preliminary evidence of axonal degeneration in the temporal lobe","volume":"28","author":"Huang","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3233\/JAD-150202_ref94","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0891988709335800","article-title":"White matter hyperintensities and cognitive dysfunction in Alzheimer disease","volume":"22","author":"Heo","year":"2009","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-150202_ref95","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2010-100234","article-title":"Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: A DTI follow-up study","volume":"22","author":"Teipel","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref96","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mrm.20741","article-title":"Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images","volume":"55","author":"Ennis","year":"2006","journal-title":"Magn Reson Med"},{"key":"10.3233\/JAD-150202_ref97","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.neuroimage.2010.12.008","article-title":"DTI measures in crossing-fibre areas: Increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer\u2019s disease","volume":"55","author":"Douaud","year":"2011","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref98","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pscychresns.2011.05.012","article-title":"Multicenter stability of diffusion tensor imaging measures: A European clinical and physical phantom study","volume":"194","author":"Teipel","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-150202_ref99","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jalz.2011.05.2416","article-title":"Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer\u2019s disease","volume":"8","author":"Mielke","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref100","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1523\/JNEUROSCI.4437-12.2013","article-title":"Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer\u2019s disease","volume":"33","author":"Douaud","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150202_ref101","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-2012-121603","article-title":"Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment","volume":"33","author":"Selnes","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1023832305702","article-title":"Alzheimer\u2019s disease as a disconnection syndrome?","volume":"13","author":"Delbeuck","year":"2003","journal-title":"Neuropsychol Rev"},{"key":"10.3233\/JAD-150202_ref103","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0896-6273(03)00758-X","article-title":"Diffusion MRI of complex neural architecture","volume":"40","author":"Tuch","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-150202_ref104","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/mrm.20279","article-title":"Q-ball imaging","volume":"52","author":"Tuch","year":"2004","journal-title":"Magn Reson Med"},{"key":"10.3233\/JAD-150202_ref105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroimage.2005.03.042","article-title":"Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain","volume":"27","author":"Assaf","year":"2005","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref107","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.mri.2011.04.006","article-title":"Non-Gaussian diffusion imaging: A brief practical review","volume":"29","author":"De Santis","year":"2011","journal-title":"Magn Reson Imaging"},{"key":"10.3233\/JAD-150202_ref108","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mrm.20508","article-title":"Diffusional kurtosis imaging: The quantification of non-gaussian water diffusion by means of magnetic resonance imaging","volume":"53","author":"Jensen","year":"2005","journal-title":"Magn Reson Med"},{"key":"10.3233\/JAD-150202_ref109","doi-asserted-by":"crossref","first-page":"W26","DOI":"10.2214\/AJR.13.11365","article-title":"Diffusion kurtosis imaging: An emerging technique for evaluating the microstructural environment of the brain","volume":"202","author":"Steven","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.3233\/JAD-150202_ref110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/nbm.1506","article-title":"MR diffusion kurtosis imaging for neural tissue characterization","volume":"23","author":"Wu","year":"2010","journal-title":"NMR Biomed"},{"key":"10.3233\/JAD-150202_ref111","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/nbm.1518","article-title":"MRI quantification of non-Gaussian water diffusion by kurtosis analysis","volume":"23","author":"Jensen","year":"2010","journal-title":"NMR Biomed"},{"key":"10.3233\/JAD-150202_ref112","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3174\/ajnr.A3553","article-title":"Novel white matter tract integrity metrics sensitive to Alzheimer disease progression","volume":"34","author":"Fieremans","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3233\/JAD-150202_ref113","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.mri.2013.02.008","article-title":"Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer\u2019s disease","volume":"31","author":"Falangola","year":"2013","journal-title":"Magn Reson Imaging"},{"key":"10.3233\/JAD-150202_ref114","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.neurobiolaging.2013.12.001","article-title":"Non-Gaussian water diffusion in aging white matter","volume":"35","author":"Coutu","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/jmri.21604","article-title":"Age-related non-Gaussian diffusion patterns in the prefrontal brain","volume":"28","author":"Falangola","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.3233\/JAD-150202_ref116","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S1053-8119(03)00336-7","article-title":"How to correct susceptibility distortions in spin-echo echo-planar images: Application to diffusion tensor imaging","volume":"20","author":"Andersson","year":"2003","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref117","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/mrm.24809","article-title":"Slice accelerated diffusion-weighted imaging at ultra-high field strength","volume":"71","author":"Eichner","year":"2014","journal-title":"Magn Reson Med"},{"key":"10.3233\/JAD-150202_ref118","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.22484","article-title":"White matter lesions defined by diffusion tensor imaging in older adults","volume":"70","author":"Back","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150202_ref119","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.14131448","article-title":"MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease","volume":"271","author":"Cosottini","year":"2014","journal-title":"Radiology"},{"key":"10.3233\/JAD-150202_ref120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/21678421.2013.844168","article-title":"Multimodal tract-based analysis in ALS patients at 7T: A specific white matter profile?","volume":"15","author":"Verstraete","year":"2014","journal-title":"Amyotroph Lateral SclerFrontotemporal Degener"},{"key":"10.3233\/JAD-150202_ref121","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.pneurobio.2011.06.004","article-title":"Staging Alzheimer\u2019s disease progression with multimodality neuroimaging","volume":"95","author":"Ewers","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-150202_ref122","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuroimage.2006.09.011","article-title":"Biological parametric mapping: A statistical toolbox for multimodality brain image analysis","volume":"34","author":"Casanova","year":"2007","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref123","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.neuroimage.2006.10.007","article-title":"Integrating VBM into the General Linear Model with voxelwise anatomical covariates","volume":"34","author":"Oakes","year":"2007","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref124","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroimage.2011.04.046","article-title":"Biological parametric mapping with robust and non-parametric statistics","volume":"57","author":"Yang","year":"2011","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmp.2008.01.005","article-title":"A reconstruction of the conductive phenomena elicited by transcranial magnetic stimulation in heterogeneous brain tissue","volume":"24","author":"Toschi","year":"2008","journal-title":"Phys Med"},{"key":"10.3233\/JAD-150202_ref126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jpsychires.2008.04.008","article-title":"Transcranial magnetic stimulation in heterogeneous brain tissue: Clinical impact on focality, reproducibility and true sham stimulation","volume":"43","author":"Toschi","year":"2009","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-150202_ref127","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00702-014-1344-6","article-title":"Subjective memory impairment and cholinergic transmission: A TMS study","volume":"122","author":"Nardone","year":"2015","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-150202_ref128","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.neubiorev.2012.01.004","article-title":"Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review","volume":"36","author":"Orru","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-150202_ref129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2047-217X-3-28","article-title":"How machine learning is shaping cognitive neuroimaging","volume":"3","author":"Varoquaux","year":"2014","journal-title":"Gigascience"},{"key":"10.3233\/JAD-150202_ref130","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.neurobiolaging.2013.06.015","article-title":"How early can we predict Alzheimer\u2019s disease using computational anatomy?","volume":"34","author":"Adaszewski","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref131","first-page":"428","article-title":"Identification of mild Alzheimer\u2019s disease through automated classification of structural MRI features","volume":"2012","author":"Diciotti","year":"2012","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"10.3233\/JAD-150202_ref132","doi-asserted-by":"crossref","first-page":"e32441","DOI":"10.1371\/journal.pone.0032441","article-title":"Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment","volume":"7","author":"O\u2019Dwyer","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-150202_ref133","doi-asserted-by":"crossref","first-page":"e21745","DOI":"10.1371\/journal.pone.0021745","article-title":"Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer\u2019s disease","volume":"6","author":"O\u2019Dwyer","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-150202_ref134","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2011.00075","article-title":"Decoding continuous variables from neuroimaging data:Basic and clinical applications","volume":"5","author":"Cohen","year":"2011","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-150202_ref135","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.media.2014.04.006","article-title":"Multiple instance learning for classification of dementia in brain MRI","volume":"18","author":"Tong","year":"2014","journal-title":"Med Image Anal"},{"key":"10.3233\/JAD-150202_ref136","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.nicl.2013.05.004","article-title":"Accurate multimodal probabilistic prediction of conversion to Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"2","author":"Young","year":"2013","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-150202_ref137","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.neurobiolaging.2012.08.013","article-title":"Increased working memory-related brain activity in middle-aged women with cognitive complaints","volume":"34","author":"Dumas","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref138","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archgenpsychiatry.2011.80","article-title":"Evidence of neuronal compensation during episodic memory in subjective memory impairment","volume":"68","author":"Erk","year":"2011","journal-title":"Arch GenPsychiatry"},{"key":"10.3233\/JAD-150202_ref139","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.eurpsy.2010.07.003","article-title":"Subjective cognitive impairment: Functional MRI during a divided attention task","volume":"26","author":"Rodda","year":"2011","journal-title":"Eur Psychiatry"},{"key":"10.3233\/JAD-150202_ref140","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/gps.2207","article-title":"Subjective cognitive impairment: Increased prefrontal cortex activation compared to controls during an encoding task","volume":"24","author":"Rodda","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-150202_ref141","doi-asserted-by":"crossref","first-page":"17654","DOI":"10.1073\/pnas.1410233111","article-title":"Elevated hippocampal resting-state connectivity underlies deficient neurocognitive function in aging","volume":"111","author":"Salami","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150202_ref142","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1602\/neurorx.1.2.206","article-title":"Molecular neuroimaging in Alzheimer\u2019s disease","volume":"1","author":"Jagust","year":"2004","journal-title":"NeuroRx"},{"key":"10.3233\/JAD-150202_ref143","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150202_ref144","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: A prospective cohort study","volume":"11","author":"Clark","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150202_ref145","first-page":"833","article-title":"[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid beta detection in living subjects with normal pressure hydrocephalus: Pooled analysis of four studies","volume":"124","author":"Rinne","year":"2012","journal-title":"ActaNeuropathol"},{"issue":"Suppl 3","key":"10.3233\/JAD-150202_ref146","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2011-0068","article-title":"Florbetaben to trace amyloid-beta in the Alzheimer brain by means of PET","volume":"26","author":"Barthel","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref147","first-page":"1778","article-title":"Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer\u2019s disease","volume":"47","author":"Mosconi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-150202_ref148","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150202_ref149","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.biopsych.2007.05.030","article-title":"Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints","volume":"63","author":"Mosconi","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-150202_ref150","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2967\/jnumed.111.090902","article-title":"Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment","volume":"52","author":"Herholz","year":"2011","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-150202_ref151","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archneurol.2008.1","article-title":"Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment","volume":"65","author":"Caselli","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150202_ref152","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"key":"10.3233\/JAD-150202_ref153","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref154","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jalz.2012.10.007","article-title":"Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u2019s disease dementia, mild cognitive impairment, and normal aging","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00259-013-2562-0","article-title":"Five-year follow-up of 11C-PIB uptake in Alzheimer\u2019s disease and MCI","volume":"41","author":"Kemppainen","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-150202_ref156","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"10.3233\/JAD-150202_ref157","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.neurobiolaging.2011.09.006","article-title":"Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia","volume":"32","author":"Klunk","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref158","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150202_ref159","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref160","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-140678","article-title":"Amyloid-beta related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults","volume":"43","author":"Hollands","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref161","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3181d3e3e9","article-title":"Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB","volume":"74","author":"Resnick","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref162","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1212\/WNL.0b013e31826e9ae6","article-title":"Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults","volume":"79","author":"Lim","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref163","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","article-title":"Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study","volume":"79","author":"Doraiswamy","year":"2012","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref164","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jalz.2013.11.005","article-title":"Abeta and cognitive change: Examining the preclinical and prodromal stages of Alzheimer\u2019s disease","volume":"10","author":"Lim","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref165","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archneurol.2011.123","article-title":"Longitudinal change of biomarkers in cognitive decline","volume":"68","author":"Lo","year":"2011","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150202_ref166","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150202_ref167","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ana.23816","article-title":"Brain injury biomarkers are not dependent on beta-amyloid in normal elderly","volume":"73","author":"Knopman","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150202_ref168","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrneurol.2013.21","article-title":"Alzheimer disease: Abeta-independent processes-rethinking preclinical AD","volume":"9","author":"Chetelat","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-150202_ref169","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/WNL.0000000000001209","article-title":"Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression","volume":"84","author":"Caroli","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-150202_ref170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: Early progress and future directions","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150202_ref171","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/ajp.156.4.531","article-title":"Association between memory complaints and incident Alzheimer\u2019s disease in elderly people with normal baseline cognition","volume":"156","author":"Geerlings","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-150202_ref172","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.jalz.2007.10.008","article-title":"Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"4","author":"Jackson","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150202_ref173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000322202","article-title":"EEG abnormalities are associated with different cognitive profiles in Alzheimer\u2019s disease","volume":"31","author":"Smits","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-150202_ref174","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.neuroimage.2006.05.033","article-title":"Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer\u2019s disease","volume":"32","author":"Stam","year":"2006","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150202_ref175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neurobiolaging.2005.07.021","article-title":"Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging","volume":"27","author":"Prichep","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150202_ref176","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1142\/S0219635206001021","article-title":"EEG markers for cognitive decline in elderly subjects with subjective memory complaints","volume":"5","author":"Alexander","year":"2006","journal-title":"J Integr Neurosci"},{"key":"10.3233\/JAD-150202_ref177","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/JAD-2012-120646","article-title":"C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer\u2019s disease","volume":"33","author":"Chapman","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref180","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite: Measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.3233\/JAD-150202_ref181","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-143006","article-title":"Biomarkers in sporadic and familial Alzheimer\u2019s disease","volume":"47","author":"Lista","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150202_ref182","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/bmm.11.50","article-title":"Role of amyloid \u03b21-42 and neuroimaging biomarkers in Alzheimer\u2019s disease","volume":"5","author":"Lista","year":"2011","journal-title":"Biomark Med"},{"key":"10.3233\/JAD-150202_ref183","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000327756","article-title":"Cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: The present and the future","volume":"8","author":"Ghidoni","year":"2011","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-150202_ref186","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2174\/1389450115666140225104705","article-title":"Can trehalose prevent neurodegeneration? Insights from experimental studies","volume":"15","author":"Emanuele","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.3233\/JAD-150202_ref187","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.archger.2014.10.011","article-title":"Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"60","author":"Gao","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"key":"10.3233\/JAD-150202_ref188","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12883-015-0268-6","article-title":"Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:01:17Z","timestamp":1777370477000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150202"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Tales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Christopher","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Gordon","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Judith","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Tony","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,24]]},"references-count":183,"journal-issue":{"issue":"s1"},"URL":"https:\/\/doi.org\/10.3233\/jad-150202","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,24]]}}}